CHU de Limoges

Running trials

• Not yet recruiting

  Follow-up After Oncological Resection by Endoscopic Colorectal ESD (Endoscopic Submucosal Dissection)

  NCT07871227· Source

• Not yet recruiting

  Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

  NCT07463768· Phase 2· Source

• Recruiting

  Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

  NCT07299071· Source

• Recruiting

  Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

  NCT07257289· Source

• Recruiting

  Integrating AI in Stroke Neurorehabilitation

  NCT07138495· Source

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Source

• Recruiting

  Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy

  NCT06588322· Source

• Recruiting

  Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer

  NCT06712472· Phase 3· Source

• Recruiting

  Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZEPHYR® Valves Versus Endoscopic Volume Reduction With One-stage ZEPHYR® Valves

  NCT06181357· Source

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· Source

• Recruiting

  Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

  NCT06027632· Source

• Recruiting

  A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

  NCT06022159· Phase 2· Source

• Recruiting

  Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

  NCT06053619· Source

• Recruiting

  Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

  NCT06022016· Source

• Active, not recruiting

  Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

  NCT05999604· Phase 3· Source

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Source

• Recruiting

  IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

  NCT05742607· Phase 2· Source

• Recruiting

  Evaluation of the Effectiveness of the Parkinson Specialized Teams Intervention

  NCT05433441· Source

• Recruiting

  Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

  NCT05378204· Source

• Recruiting

  Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

  NCT05236803· Source

• Active, not recruiting

  Observatory of Patients With Haemophilia B Treated by IdElvion®

  NCT05086575· Source

• Active, not recruiting

  Onco-haematology Vigilance Card

  NCT04931329· Source

• Active, not recruiting

  A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

  NCT04628494· Phase 3· Source

• Active, not recruiting

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· Phase 3· Source

• Active, not recruiting

  Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism

  NCT04304651· Source

• Recruiting

  French Colorectal ESD Cohort in Experts Centers

  NCT04592003· Source

• Active, not recruiting

  Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

  NCT03981003· Source

• Active, not recruiting

  OFSEP High Definition Cohort

  NCT03603457· Source

• Active, not recruiting

  International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

  NCT03386734· Source

• Active, not recruiting

  Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

  NCT02947685· Phase 3· Source

• Active, not recruiting

  Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

  NCT02767063· Phase 1/2· Source

• Recruiting

  French National Database of Rare Dermatological Cancers

  NCT03210935· Source

• Active, not recruiting

  A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

  NCT01957436· Phase 3· Source

• Active, not recruiting

  Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function

  NCT00760331· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Colorectal cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Stroke2 recruiting
• Autism1 recruiting
• Chronic kidney disease1 recruiting
• COPD1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Heart failure1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroblastoma1 recruiting
• Ovarian cancer1 recruiting
• Parkinson disease1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  How Stroke Affects Leg Muscles When Walking

  NCT07504627· Source

• Withdrawn

  Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study

  NCT05314140· Source

• Completed

  Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy

  NCT05594576· Source

• Completed

  Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia

  NCT05225935· Source

• Completed

  Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer

  NCT04939324· Source

• Terminated

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· Phase 3· Source

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· Source

• Terminated

  Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

  NCT03765541· Phase 3· Source

• Completed

  Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

  NCT03455582· Source

• Completed

  A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.

  NCT03422328· Phase 3· Source

• Completed

  Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

  NCT01868269· Phase 3· Source